Aurinia Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-18.7M | $-18.7M | $15.0K | — |
| FY2017 | $-41.2M | $-41.2M | $25.0K | $4.2M |
| FY2018 | $-51.6M | $-51.6M | $30.0K | $6.9M |
| FY2019 | $-63.6M | $-63.7M | $87.0K | $7.4M |
| FY2020 | $-69.9M | $-69.9M | — | $17.5M |
| FY2021 | $-157.7M | $-157.7M | — | $31.2M |
| FY2022 | $-79.5M | $-79.5M | — | $32.3M |
| FY2023 | $-33.5M | $-33.5M | — | $45.3M |
| FY2024 | $44.4M | $44.4M | — | $31.6M |
| FY2025 | $135.7M | $135.7M | — | $14.7M |